From: ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression
Variable | Relative Risk | 95% CI | p-value |
---|---|---|---|
ADAM9 | 1.081 | 0.433–2.696 | 0.868 |
pT-status | 6.820 | 1.462–31.827 | 0.015 |
Grading | 1.060 | 0.434–2.589 | 0.899 |
Metastasis | 1.496 | 1.534–13.177 | 0.006 |